BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10784021)

  • 21. Purpura fulminans in paroxysmal nocturnal haemoglobinuria.
    Watt SG; Winhoven S; Hay CR; Lucas GS
    Br J Haematol; 2007 May; 137(4):271. PubMed ID: 17456051
    [No Abstract]   [Full Text] [Related]  

  • 22. [Meningococcal purpura fulminans: treatment with recombinant protein C activator in 3 cases].
    Salinas U; Unzueta J; Vidarte MA; Rodrigo MP; Gómez JJ; Aguilera L
    Rev Esp Anestesiol Reanim; 2007 Oct; 54(8):503-6. PubMed ID: 17993100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary disease with hemorrhage in Henoch-Schöenlein purpura.
    Olson JC; Kelly KJ; Pan CG; Wortmann DW
    Pediatrics; 1992 Jun; 89(6 Pt 2):1177-81. PubMed ID: 1594373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case report of purpura fulminans secondary to transient protein C deficiency as a complication of chickenpox infection.
    Ozsoylu S
    Turk J Pediatr; 2003; 45(1):83; author reply 84. PubMed ID: 12718382
    [No Abstract]   [Full Text] [Related]  

  • 25. Purpura fulminans in children: report of two cases.
    Hwang CC; Jaing TH; Chiu CH
    Acta Paediatr Taiwan; 1999; 40(2):119-20. PubMed ID: 10910600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Meningococcal purpura fulminans].
    Mouloungui C; Ndinga JP; Nzoghe P; Tchoua R; Saïssy JM; Moulin O
    Presse Med; 2003 Apr; 32(14):646. PubMed ID: 12735301
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombolytic therapy in children--clinical experiences with recombinant tissue-plasminogen activator.
    Knöfler R; Dinger J; Kabus M; Müller D; Lauterbach I; Rupprecht E; Taut-Sack H; Weissbach G
    Semin Thromb Hemost; 2001; 27(2):169-74. PubMed ID: 11372772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradoxical embolus illustrating speed of action of recombinant tissue plasminogen activator in massive pulmonary embolism.
    Madani H; Ransom PA
    Emerg Med J; 2007 Jun; 24(6):441. PubMed ID: 17513552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Postvaricella purpura fulminans].
    Alsina Manrique de Lara L; Zambudio Sert S; Pizà Oliveras A; Toll Costa T; García García JJ; Luaces Cubells C
    An Pediatr (Barc); 2004 Jun; 60(6):585-8. PubMed ID: 15207173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent purpura fulminans associated with drug-resistant Streptococcus pneumoniae infection in an asplenic girl.
    Pancharoen C; Chatchatee P; Ngamphaiboon J; Thisyakorn U
    Pediatr Infect Dis J; 2002 Jan; 21(1):80-1. PubMed ID: 11791110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Post-chickenpox purpura fulminans with transient reduction of C and S proteins].
    Angeles Fernández G; Villanueva Lamas J; Cambra FJ; Toll MT; Palomeque Rico A
    An Esp Pediatr; 1998 Oct; 49(4):412-4. PubMed ID: 9859560
    [No Abstract]   [Full Text] [Related]  

  • 32. Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe Henoch Schönlein nephritis?
    Shin JI; Park SJ; Kim JH
    Kidney Int; 2011 Apr; 79(8):922. PubMed ID: 21451539
    [No Abstract]   [Full Text] [Related]  

  • 33. Theoretic and practical considerations on laboratory monitoring of thrombolytic therapy.
    Conard J; Samama MM
    Semin Thromb Hemost; 1987 Apr; 13(2):212-22. PubMed ID: 3114887
    [No Abstract]   [Full Text] [Related]  

  • 34. [Massive gastrointestinal hemorrhage in the course of Schoenlein-Henoch purpura in an 8-year old girl].
    Mroczkowska-Juchkiewicz A; Pawłowska-Kamieniak A; Szczepanowska A; Papierkowski A
    Pol Merkur Lekarski; 1997 Aug; 3(14):81-2. PubMed ID: 9480183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
    de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
    Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of acute infectious purpura fulminans with activated protein C.
    Lokeshwar MR; Singhal T; Udani SV; Kapadia FN
    Indian Pediatr; 2006 Jun; 43(6):535-8. PubMed ID: 16820663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Magnetic resonance imaging for detection of rotational deformities in children with femoral shaft fractures treated by the ESIN method].
    Plánka L; Chalupová P; Charvátová M; Poul J; Gál P
    Acta Chir Orthop Traumatol Cech; 2010 Feb; 77(1):39-42. PubMed ID: 20214859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purpura fulminans caused by group A beta-hemolytic Streptococcus sepsis.
    Dhodapkar K; Corbacioglu S; Chang MW; Karpatkin M; DiMichele D
    J Pediatr; 2000 Oct; 137(4):562-7. PubMed ID: 11035839
    [No Abstract]   [Full Text] [Related]  

  • 39. Musculoskeletal sequelae of Varicella-zoster infection: two case reports.
    Lim JB; Huntley JS
    Scott Med J; 2012 May; 57(2):121. PubMed ID: 22555234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.